메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색
질문

논문 기본 정보

자료유형
학술저널
저자정보
Eunhwan Bae (Inha University) Donggyu Kim (Inha University) Younghoon Kim (Seoul National University) Minhye Shin (Inha University)
저널정보
대한미생물학회 JOURNAL OF BACTERIOLOGY AND VIROLOGY JOURNAL OF BACTERIOLOGY AND VIROLOGY Vol.54 No.4
발행연도
2024.12
수록면
312 - 324 (13page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색
질문

초록· 키워드

오류제보하기
In modern medicine, the discovery of antibiotics has been critical for the treatment of pathogenic infections. However, their overuse and misuse have led to the emergence of antibiotic-resistant bacteria, causing a global public health crisis with significant morbidity and mortality. Notably, methicillin-resistant Staphylococcus aureus (MRSA) is a major opportunistic pathogen in hospital-acquired infections, highlighting the urgent need for new antimicrobial agents or vaccines. This study proposes a strategy for discovering novel anti-virulence agents by targeting SaeS, a key histidine kinase in the SaeRS two-component system in S. aureus, which plays a key role in regulating virulence factors. We applied in silico molecular docking predictions to screen potential SaeS inhibitors among natural small compounds based on their binding scores with SaeS. The selected candidate compounds were subsequently analyzed for their effects on bacterial growth and staphyloxanthin production, a major virulence regulon of the SaeRS system. Our results showed that riboflavin (vitamin B2) inhibited staphyloxanthin production depending on the presence of SaeS and its concentration. These results suggest that virtual screening of molecules can be an effective strategy for the discovery of new anti-virulence agents targeting bacterial infections.

목차

INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0

UCI(KEPA) : I410-151-25-02-092190316